These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

241 related items for PubMed ID: 15703837

  • 1. A combination of docosahexaenoic acid and celecoxib prevents prostate cancer cell growth in vitro and is associated with modulation of nuclear factor-kappaB, and steroid hormone receptors.
    Narayanan NK, Narayanan BA, Reddy BS.
    Int J Oncol; 2005 Mar; 26(3):785-92. PubMed ID: 15703837
    [Abstract] [Full Text] [Related]

  • 2. Regression of mouse prostatic intraepithelial neoplasia by nonsteroidal anti-inflammatory drugs in the transgenic adenocarcinoma mouse prostate model.
    Narayanan BA, Narayanan NK, Pittman B, Reddy BS.
    Clin Cancer Res; 2004 Nov 15; 10(22):7727-37. PubMed ID: 15570007
    [Abstract] [Full Text] [Related]

  • 3. Adenocarcina of the mouse prostate growth inhibition by celecoxib: downregulation of transcription factors involved in COX-2 inhibition.
    Narayanan BA, Narayanan NK, Pttman B, Reddy BS.
    Prostate; 2006 Feb 15; 66(3):257-65. PubMed ID: 16175586
    [Abstract] [Full Text] [Related]

  • 4. Prevention of colon cancer by low doses of celecoxib, a cyclooxygenase inhibitor, administered in diet rich in omega-3 polyunsaturated fatty acids.
    Reddy BS, Patlolla JM, Simi B, Wang SH, Rao CV.
    Cancer Res; 2005 Sep 01; 65(17):8022-7. PubMed ID: 16140976
    [Abstract] [Full Text] [Related]

  • 5. Exisulind in combination with celecoxib modulates epidermal growth factor receptor, cyclooxygenase-2, and cyclin D1 against prostate carcinogenesis: in vivo evidence.
    Narayanan BA, Reddy BS, Bosland MC, Nargi D, Horton L, Randolph C, Narayanan NK.
    Clin Cancer Res; 2007 Oct 01; 13(19):5965-73. PubMed ID: 17908994
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Combined inhibitory effects of green tea polyphenols and selective cyclooxygenase-2 inhibitors on the growth of human prostate cancer cells both in vitro and in vivo.
    Adhami VM, Malik A, Zaman N, Sarfaraz S, Siddiqui IA, Syed DN, Afaq F, Pasha FS, Saleem M, Mukhtar H.
    Clin Cancer Res; 2007 Mar 01; 13(5):1611-9. PubMed ID: 17332308
    [Abstract] [Full Text] [Related]

  • 8. Celecoxib inhibits prostate cancer growth: evidence of a cyclooxygenase-2-independent mechanism.
    Patel MI, Subbaramaiah K, Du B, Chang M, Yang P, Newman RA, Cordon-Cardo C, Thaler HT, Dannenberg AJ.
    Clin Cancer Res; 2005 Mar 01; 11(5):1999-2007. PubMed ID: 15756026
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Inhibition of cyclooxygenase-2 activity by celecoxib does not lead to radiosensitization of human prostate cancer cells in vitro.
    Ohneseit PA, Krebiehl G, Dittmann K, Kehlbach R, Rodemann HP.
    Radiother Oncol; 2007 Feb 01; 82(2):229-38. PubMed ID: 17207548
    [Abstract] [Full Text] [Related]

  • 11. Celecoxib and curcumin synergistically inhibit the growth of colorectal cancer cells.
    Lev-Ari S, Strier L, Kazanov D, Madar-Shapiro L, Dvory-Sobol H, Pinchuk I, Marian B, Lichtenberg D, Arber N.
    Clin Cancer Res; 2005 Sep 15; 11(18):6738-44. PubMed ID: 16166455
    [Abstract] [Full Text] [Related]

  • 12. Chemoprevention of familial adenomatous polyposis by low doses of atorvastatin and celecoxib given individually and in combination to APCMin mice.
    Swamy MV, Patlolla JM, Steele VE, Kopelovich L, Reddy BS, Rao CV.
    Cancer Res; 2006 Jul 15; 66(14):7370-7. PubMed ID: 16849589
    [Abstract] [Full Text] [Related]

  • 13. Atorvastatin and celecoxib inhibit prostate PC-3 tumors in immunodeficient mice.
    Zheng X, Cui XX, Avila GE, Huang MT, Liu Y, Patel J, Kong AN, Paulino R, Shih WJ, Lin Y, Rabson AB, Reddy BS, Conney AH.
    Clin Cancer Res; 2007 Sep 15; 13(18 Pt 1):5480-7. PubMed ID: 17875778
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Signal transduction pathways regulating cyclooxygenase-2 expression: potential molecular targets for chemoprevention.
    Chun KS, Surh YJ.
    Biochem Pharmacol; 2004 Sep 15; 68(6):1089-100. PubMed ID: 15313405
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Failure of apoptosis and activation on NFkappaB by celecoxib and aspirin in lung cancer cell lines.
    Gradilone A, Silvestri I, Scarpa S, Morrone S, Gandini O, Pulcinelli FM, Gianni W, Frati L, Aglianò AM, Gazzaniga P.
    Oncol Rep; 2007 Apr 15; 17(4):823-8. PubMed ID: 17342322
    [Abstract] [Full Text] [Related]

  • 20. Increased expression of cyclooxygenase-2 correlates with resistance to radiation in human prostate adenocarcinoma cells.
    Anai S, Tanaka M, Shiverick KT, Kim W, Takada S, Boehlein S, Goodison S, Mizokami A, Rosser CJ.
    J Urol; 2007 May 15; 177(5):1913-7. PubMed ID: 17437847
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.